<scp>TAS</scp> 3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer

Shohei Yoshida(Taiho Pharmaceutical (Japan)), Kazuhisa Minamiguchi(Taiho Pharmaceutical (Japan))
Molecular Oncology
April 10, 2024
Cited by 8


Related Papers

No related papers found

Powered by citation graph analysis